Press Releases

Press Releases

Filter By:
close-up image of a mind bending brain probe

Futuristic brain probe allows for wireless control of neurons

Thursday, July 16, 2015
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light

Progesterone does not significantly improve outcome after traumatic brain injury

Tuesday, June 16, 2015
NIH-funded study reveals treatment does not show benefit over placebo following head injury
microscopic image of neuronal firing patterns

Normal neuronal firing may spark brain tumor growth

Tuesday, June 16, 2015
NIH-funded study opens new path to discovering brain cancer treatments
photo of Dr. Walter J. Koroshetz

NIH Names Walter J. Koroshetz, M.D. Director of the National Institute of Neurological Disorders and Stroke

Thursday, June 11, 2015
National Institutes of Health Director Francis S. Collins, M.D., Ph.D. announced today the selection of Walter J. Koroshetz, M.D., as the Director of the National Institute of Neurological Disorders and Stroke (NINDS).  He has served as Acting Director of the NINDS since October, 2014. 
microscopic image of ALS and FTD in a mouse

Scientists create mice with a major genetic cause of ALS and FTD

Friday, May 22, 2015
NIH-funded study provides new platform for testing treatments for several neurodegenerative disorders
image of tech assisting patient in an MRI machine

A SMARTer approach to stroke care

Wednesday, May 13, 2015
NIH study uses MRI scans to screen stroke patients for acute treatment within the first critical 60 minutes
TTLL7 (gold structures on the left) impacts cell function by binding to microtubules (silver structure made up of purple and yellow subunits) and adding chemical markers to the surface.

Scientists unravel the mystery of the tubulin code

Tuesday, May 12, 2015
NIH study provides a glimpse into the code that controls variety of cell functions
image of a brain scan

Study points to possible treatment for lethal pediatric brain cancer

Monday, May 4, 2015
NIH-funded preclinical study suggests epigenetic drugs may be used to treat leading cause of pediatric brain cancer death
An artist’s representation of the study. Scientists found that certain drugs were able to promote remyelination in mouse models of multiple sclerosis

Drugs that activate brain stem cells may reverse multiple sclerosis in mice

Monday, April 20, 2015
NIH-funded study identifies over-the-counter compounds that may replace damaged cells

Pages